Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

The company was incorporated in 2004 and is based in Isfiya, Israel.

Check-Cap Ltd.

Country	Israel
Founded	2004
IPO Date	Feb 19, 2015
Industry	Diagnostics & Research
Sector	Healthcare
Employees	85
CEO	Saar Levi

Contact Details

Address: Check-Cap Building, 29 Abba Hushi Avenue Isfiya, 3009000 Israel
Phone	972 4 830 3401
Website	check-cap.com

Stock Details

Ticker Symbol	CHEK
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001610590
CUSIP Number	M2361E203
ISIN Number	IL0011336851
SIC Code	3844

Key Executives

Name	Position
Dr. Yoav Kimchy Ph.D.	Founder, Head of Research & Development and Member of Scientific Advisory Board
David Benaim	Interim Chief Financial Officer
Noa Reshef M.B.A.	Head of Operations

Latest SEC Filings

Date	Type	Title
Sep 13, 2024	6-K	Report of foreign issuer
Aug 5, 2024	6-K	Report of foreign issuer
May 15, 2024	20-F	Annual and transition report of foreign private issuers
May 1, 2024	NT 20-F	Notification of inability to timely file Form 20-F
Apr 29, 2024	6-K	Report of foreign issuer
Apr 15, 2024	6-K	Report of foreign issuer
Apr 10, 2024	6-K/A	Filing
Apr 8, 2024	SC 13D/A	[Amend] General statement of acquisition of beneficial ownership
Apr 8, 2024	6-K	Report of foreign issuer
Apr 5, 2024	6-K	Report of foreign issuer

View All SEC Filings